Concepedia

Aaron D. Krabill

AD

Statistics

Publications

6

Citations

246

H-Index

6

Active since

2019

Affiliations

Purdue University West Lafayette(Current)

Center for Cancer Research

Mayo Clinic

Aaron D. Krabill is an author at Purdue University West Lafayette specializing in molecular biology, antimicrobial drug development, and pharmacy.

ORCID

Publications per year

2019–2024

6

Publications

6

Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant <i>Enterococcus</i>

Jatinder Kaur, Xufeng Cao, Nader S. Abutaleb et al. · Journal of Medicinal Chemistry · 2020 · 86 citations · Full text

, , +14

Structure–Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against <i>Neisseria gonorrhoeae</i>

Chad S. Hewitt, Nader S. Abutaleb, Ahmed E. M. Elhassanny et al. · ACS Infectious Diseases · 2021 · 82 citations · Full text

, , +17

Ubiquitin C‐Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine‐Based Inhibitor

Aaron D. Krabill, Hao Chen, Sajjad Hussain et al. · ChemBioChem · 2019 · 41 citations · Full text

, , +9

Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases

Chad S. Hewitt, Aaron D. Krabill, Chittaranjan Das et al. · Biochemistry · 2020 · 14 citations

, , +15

Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1

Ryan D. Imhoff, Rishi Patel, Muhammad Hassan Safdar et al. · Journal of Medicinal Chemistry · 2024 · 12 citations

, , +17

1–5 of 6